 |
 |
 |
For Market’s Latest Update Join Us on Telegram
 |
Corona Remedies IPO GMP
Corona Remedies IPO is a Mainboard IPO, the company will raise up to 61,71,101 shares (Aggregating up to ₹655.37 crore) via this IPO. The IPO comprises a fresh issue of NIL, and an offer for sale (OFS) of shares (amount) 61,71,101 shares (Aggregating up to ₹655.37 crore).
Corona Remedies IPO will open for subscription on 8 December 2025 and close on 10 December 2025. Basis of Allotment will be decided on 11 December 2025, initiation of refund will begin on 12 December 2025 and finally IPO will be listed on 15 December 2025 at NSE, BSE. IIFL Capital Services Ltd, JM Financial Ltd and Kotak Mahindra Capital Co Ltd is the book running lead manager and Bigshare Services Pvt Ltd is the registrar of the Corona Remedies IPO.
Total shares offered by Corona Remedies IPO is 61,71,101 shares (Aggregating up to ₹655.37 crore). Out of which Not more than 35% of the net offer is reserved for retail, Not more than 15% of the net offer is reserved for HNI (NII), Not less than 50% of the net offer is reserved for QIB.
Corona Remedies IPO Price Band and Market Lot
Corona Remedies has set a price band of ₹1008 to ₹1062 per share and lot size is of 14 shares. Retail investors can bid for a minimum of 1 lots (14 shares), requiring minimum investment of ₹14,868, and maximun upto 13 lots (182 shares), requiring maximum investment of ₹1,93,284. Small HNI investors can bid for a minimum of 14 lots (196 shares), requiring an investment of ₹2,08,152, small hni (shni) investors can bid for a maximum of 67 lots (938 shares), requiring an investment of ₹9,96,156 and big hni (bHNI) investors can bid for a minimum of 68 Lots (952 shares), requiring an investment of ₹10,11,024. Calculated at the cut-off price ₹1062 per share (the upper end of the price band).
Corona Remedies IPO Subscription Status Today (Live)
Corona Remedies IPO GMP (Grey Market Premium) Today (Live)
Visit us daily to get the latest update on Corona Remedies IPO GMP. Corona Remedies IPO GMP started, and here you can get the latest update of Corona Remedies IPO GMP.
Corona Remedies IPO GMP today or grey market premium, and the Latest GMP Data pattern is available here.
- Price Band of Corona Remedies IPO is ₹1008 to ₹1062 per share.
- Current GMP (Grey Market Premium) for Corona Remedies IPO is:
- It is a premium for the Corona Remedies IPO cut-off price ₹1062 per share.
- As per Corona Remedies IPO Taday’s GMP Data, the estimated listing price of Corona Remedies IPO shares can be:
- Estimated listing price calculated as Corona Remedies IPO cutoff price or allotment price: ₹1062 per share + IPO current GMP: .
- Grey market premium (GMP) indicates investors are willing to pay more than the issue price.
- A negative GMP suggests that the IPO’s share is likely to be listed on the stock exchange at a discount, and a positive Grey Market Premium suggests that the IPO’s share is likely to be listed on the stock exchange at a profit.
- Do not subscribe for Corona Remedies IPO by just seeing the premium Price, It can change anytime
- We do not trade/deal or buy/sell Corona Remedies IPO forms in the grey market and GMP prices shown here are gathered from various sources.
| Corona Remedies IPO GMP | ||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | 288 | |
| 7 December 2025 | 325 | |
| 6 December 2025 | 325 | |
| 5 December 2025 | 365 | |
| 4 December 2025 | 365 | |
| 3 December 2025 | 300 | |
| 30 Jun 25 in crore | 31 Mar 2025 in crore | 31 Mar 24 in crore | 31 Mar 23 in crore | |
|---|---|---|---|---|
| Assets | 1,012.38 | 929.86 | 830.58 | 595.02 |
| Revenue | 348.56 | 1,202.35 | 1,020.93 | 891.1 |
| Profit After Tax | 46.2 | 149.43 | 90.5 | 84.93 |
| EBITDA | 71.8 | 245.91 | 161.19 | 135.03 |
| Net Worth | 607.02 | 606.34 | 480.41 | 408.52 |
| Total Borrowing | 106.65 | 62.7 | 134.14 | 2.33 |
| Reserves & Surplus | 545.86 | 545.18 | 419.25 | 347.36 |
| Corona Remedies IPO Time Table (Tentative) | |
| IPO Open Date | 8 December 2025 |
| IPO Close Date | 10 December 2025 |
| Basis of Allotment Date | 11 December 2025 |
| Initiation of Refunds | 12 December 2025 |
| Credit of Share to Demat Account | 12 December 2025 |
| IPO Listing Date | 15 December 2025 |
| IPO Cut-off time (UPI mandate confirmation) | 5:00 PM on 10 December 2025 |
| Corona Remedies IPO Reservation | |
| Retail Quota | Not more than 35% of the net offer |
| NII Quota | Not more than 15% of the net offer |
| QIB Quota | Not less than 50% of the net offer |
| Total | 61,71,101 shares (100.00%) |
| Corona Remedies IPO Price | |
| Face Value | ₹10 per share |
| Price Band | ₹1008 to ₹1062 per share |
| Lot Size | 14 shares |
| IPO Issue Type | Book Built Issue |
About Corona Remedies (Company Overview)
Corona Remedies Limited founded in 2004 and headquartered in Ahmedabad, Gujarat, is an India focused branded pharmaceutical formulations company specializing in chronic and sub chronic therapies such as women’s healthcare, cardiology, diabetology, pain management, and urology. The company develops, manufactures, and markets a wide range of prescription medicines through a strong domestic distribution network covering urban and semi urban markets.
The company operates multiple manufacturing facilities in India, including units in Gujarat and Himachal Pradesh, and these plants hold key quality certifications such as EU GMP and WHO GMP.
The company ranks among the top Indian pharmaceutical players by domestic branded formulations and has positioned itself strongly in chronic lifestyle segments, which provide recurring long term demand. Its financial profile is characterized by healthy profitability, strong return ratios, and low leverage, reflecting a relatively conservative balance sheet and efficient capital use.
Corona Remedies IPO Frequently Asked Questions
The latest Grey Market Premium (GMP) of Corona Remedies IPO is .
It is a premium to the IPO cut-off price Corona Remedies. GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for Corona Remedies IPO can be .
Expected listing listing price for Corona Remedies share can be .
According to latest GMP data pattern expected listing price and profit per share for Corona Remedies IPO can be . Expected listing price is calculated by adding the GMP to the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider Corona Remedies fundamentals and your risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.